The WHO has released a Global Influenza Strategy for 2019–2030 aiming to prevent seasonal flu, prepare for a pandemic situation and control the spread of zoonotic influenza.
The World Health Organization has released a new Technical Note updating countries worldwide on optimal methods and diagnostic techniques to improve antimicrobial resistance surveillance.
The UK’s Health & Social Care Select Committee has concluded that antimicrobial resistance should be established as a ‘top five policy priority’ for the UK Government.
The Joint Committee on Vaccination and Immunisation has stated that a gender-neutral vaccine program would be cost effective in the UK and would protect boys against HPV infection and associated diseases.
In this interview Sally, a Senior Research Fellow at Imperial College London’s Faculty of Medicine (London, UK), speaks about her work on issues relating to the vaccination and screening of migrants, in addition to discussing some of the wider issues facing migrant’s access to healthcare in Europe.
Population mobility and infectious diseases and infectious diseases and population mobility – direction really does matter?
Infectious diseases and population mobility are intimately linked from the perspectives of clinical practice to global health policy. Mobility bridges significant epidemiological differences in the classical determinants of health for all diseases. The new reality is that “surveillance, detection and response” activities in infectious diseases clinical care and public health are the responsibility all members of society.
A biothreat agent is defined as a biological weapon employed to deliberately cause disease, but how real are such threats, and what should our approach be towards them?
Microbial domain biological resource centers that provide researchers with access to living cultures of microorganisms have adopted a code of conduct and best practice to prevent the misappropriation and misuse of microorganisms.
A new analysis has suggested that the notion of ‘completing the course’ when taking antibiotics is not evidence-based and should be dropped as it may actually increase the risk of antibiotic resistance.
In this interview, Roy Anderson, Director for the London Centre for Neglected Tropical Disease Research speaks about the work undertaken by the Centre and gives his thoughts on the wider NTD field.